US Stock MarketDetailed Quotes

Collegium Pharmaceutical (COLL)

Watchlist
  • 33.780
  • -1.050-3.01%
Close May 15 15:59 ET
  • 33.780
  • 0.0000.00%
Post 16:10 ET
1.10BMarket Cap16.40P/E (TTM)

Collegium Pharmaceutical (COLL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.10%57.11M
60.66%329.32M
45.37%123.05M
971.63%78.44M
7.48%72.44M
-10.56%55.4M
-25.39%204.98M
15.42%84.64M
-112.16%-9M
-32.41%67.4M
Net income from continuing operations
499.75%14.5M
-9.13%62.87M
35.31%16.96M
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
Operating gains losses
----
41.18%15.99M
----
----
----
----
-51.80%11.33M
--0
--4.15M
----
Depreciation and amortization
-1.11%55.94M
33.65%226.07M
-0.21%56.4M
35.35%56.51M
59.61%56.61M
59.63%56.56M
13.34%169.16M
59.35%56.51M
12.37%41.75M
-7.54%35.47M
Deferred tax
-79.59%-968K
4.31%-25.66M
0.83%-10.07M
-38.92%-12.13M
17.05%-2.91M
87.78%-539K
-1,145.42%-26.81M
-2,904.73%-10.16M
-670.79%-8.73M
-452.36%-3.51M
Other non cash items
-45.27%799K
-18.94%5.45M
-74.64%437K
-10.80%1.48M
30.97%2.07M
-16.95%1.46M
-19.56%6.72M
-11.23%1.72M
-20.25%1.66M
-26.52%1.58M
Change In working capital
-51.88%-23.85M
106.84%3.76M
101.27%33.83M
86.70%-8.5M
-164.50%-5.86M
-179.63%-15.7M
-352.99%-54.98M
899.67%16.81M
-824.44%-63.95M
-105.56%-2.22M
-Change in receivables
-10,155.29%-17.43M
489.76%17.2M
21,240.57%22.62M
-10,913.68%-20.93M
271.13%15.68M
-103.52%-170K
-222.82%-4.41M
-95.44%106K
98.68%-190K
-178.66%-9.16M
-Change in inventory
-10.31%-1.83M
-138.44%-5.35M
-215.74%-2.86M
-98.63%96K
-127.24%-930K
-257.01%-1.66M
-1.71%13.93M
37.87%2.47M
186.25%6.99M
-50.30%3.41M
-Change in prepaid assets
140.23%4.13M
43.37%-7.97M
-320.17%-8.19M
5,016.36%21.34M
5.76%-10.85M
-5,703.39%-10.27M
-1,077.76%-14.07M
-239.44%-1.95M
-124.23%-434K
-661.81%-11.51M
-Change in payables and accrued expense
-137.35%-8.55M
100.15%74K
38.50%22.41M
87.25%-8.97M
-164.92%-9.77M
68.18%-3.6M
-2,093.71%-50.42M
312.38%16.18M
-338.29%-70.32M
-34.20%15.04M
-Change in other working capital
---167K
---197K
---152K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
3.10%57.11M
60.66%329.32M
45.37%123.05M
971.63%78.44M
7.48%72.44M
-10.56%55.4M
-25.39%204.98M
15.42%84.64M
-112.16%-9M
-32.41%67.4M
Investing cash flow
Cash flow from continuing investing activities
116.81%1.63M
77.92%-63.53M
-70.63%-20.07M
87.60%-30.87M
67.27%-2.92M
46.60%-9.68M
-306.37%-287.76M
53.13%-11.76M
-6,413.95%-248.96M
78.65%-8.91M
Net PPE purchase and sale
66.17%-270K
-5.33%-1.74M
-20.88%-689K
22.95%-188K
75.93%-65K
-40.49%-798K
-258.35%-1.65M
-247.56%-570K
-275.38%-244K
-382.14%-270K
Net business purchase and sale
----
--0
--0
----
----
----
---267.54M
--0
----
----
Net investment purchase and sale
121.36%1.9M
-232.77%-61.79M
-73.16%-19.38M
-263.03%-30.68M
67.00%-2.85M
49.42%-8.88M
73.61%-18.57M
55.11%-11.19M
600.90%18.82M
79.27%-8.64M
Cash from discontinued investing activities
Investing cash flow
116.81%1.63M
77.92%-63.53M
-70.63%-20.07M
87.60%-30.87M
67.27%-2.92M
46.60%-9.68M
-306.37%-287.76M
53.13%-11.76M
-6,413.95%-248.96M
78.65%-8.91M
Financing cash flow
Cash flow from continuing financing activities
15.43%-21.34M
-81.91%-110.25M
47.14%-21.82M
-109.94%-14.82M
57.65%-48.37M
53.39%-25.24M
56.77%-60.6M
39.14%-41.28M
256.19%149.03M
-152.47%-114.21M
Net issuance payments of debt
55.10%-7.25M
-1,036.07%-70.38M
-35.92%-21.95M
-110.87%-16.15M
79.58%-16.15M
64.77%-16.15M
111.41%7.52M
64.77%-16.15M
424.10%148.55M
-70.86%-79.05M
Net common stock issuance
----
58.18%-25.1M
--0
--0
----
----
19.97%-60.03M
-0.10%-25.03M
--0
----
Proceeds from stock option exercised by employees
-34.84%1.34M
-49.04%5.64M
469.36%985K
269.68%2.29M
-94.61%308K
-54.88%2.06M
21.67%11.07M
-94.66%173K
4.55%620K
357.15%5.72M
Net other financing activities
-38.44%-15.43M
-6.42%-20.4M
-208.60%-861K
-578.87%-964K
-26.43%-7.43M
13.41%-11.15M
-129.28%-19.17M
-19.74%-279K
17.44%-142K
-2,570.45%-5.88M
Cash from discontinued financing activities
Financing cash flow
15.43%-21.34M
-81.91%-110.25M
47.14%-21.82M
-109.94%-14.82M
57.65%-48.37M
53.39%-25.24M
56.77%-60.6M
39.14%-41.28M
256.19%149.03M
-152.47%-114.21M
Net cash flow
Beginning cash position
161.00%252.16M
-59.74%96.61M
163.05%171M
-20.52%138.25M
-49.01%117.09M
-59.74%96.61M
36.18%239.99M
-74.96%65.01M
-38.92%173.94M
-15.58%229.66M
Current changes in cash
82.59%37.4M
208.48%155.55M
156.79%81.16M
130.07%32.75M
137.97%21.15M
298.14%20.48M
-324.88%-143.38M
261.37%31.61M
-331.99%-108.93M
-536.34%-55.72M
End cash Position
147.29%289.56M
161.00%252.16M
161.00%252.16M
163.05%171M
-20.52%138.25M
-49.01%117.09M
-59.74%96.61M
-59.74%96.61M
-74.96%65.01M
-38.92%173.94M
Free cash flow
4.11%56.84M
61.11%327.58M
45.54%122.36M
946.59%78.25M
7.81%72.37M
-11.03%54.6M
-25.87%203.33M
14.90%84.07M
-112.50%-9.24M
-32.65%67.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.10%57.11M60.66%329.32M45.37%123.05M971.63%78.44M7.48%72.44M-10.56%55.4M-25.39%204.98M15.42%84.64M-112.16%-9M-32.41%67.4M
Net income from continuing operations 499.75%14.5M-9.13%62.87M35.31%16.96M237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M
Operating gains losses ----41.18%15.99M-----------------51.80%11.33M--0--4.15M----
Depreciation and amortization -1.11%55.94M33.65%226.07M-0.21%56.4M35.35%56.51M59.61%56.61M59.63%56.56M13.34%169.16M59.35%56.51M12.37%41.75M-7.54%35.47M
Deferred tax -79.59%-968K4.31%-25.66M0.83%-10.07M-38.92%-12.13M17.05%-2.91M87.78%-539K-1,145.42%-26.81M-2,904.73%-10.16M-670.79%-8.73M-452.36%-3.51M
Other non cash items -45.27%799K-18.94%5.45M-74.64%437K-10.80%1.48M30.97%2.07M-16.95%1.46M-19.56%6.72M-11.23%1.72M-20.25%1.66M-26.52%1.58M
Change In working capital -51.88%-23.85M106.84%3.76M101.27%33.83M86.70%-8.5M-164.50%-5.86M-179.63%-15.7M-352.99%-54.98M899.67%16.81M-824.44%-63.95M-105.56%-2.22M
-Change in receivables -10,155.29%-17.43M489.76%17.2M21,240.57%22.62M-10,913.68%-20.93M271.13%15.68M-103.52%-170K-222.82%-4.41M-95.44%106K98.68%-190K-178.66%-9.16M
-Change in inventory -10.31%-1.83M-138.44%-5.35M-215.74%-2.86M-98.63%96K-127.24%-930K-257.01%-1.66M-1.71%13.93M37.87%2.47M186.25%6.99M-50.30%3.41M
-Change in prepaid assets 140.23%4.13M43.37%-7.97M-320.17%-8.19M5,016.36%21.34M5.76%-10.85M-5,703.39%-10.27M-1,077.76%-14.07M-239.44%-1.95M-124.23%-434K-661.81%-11.51M
-Change in payables and accrued expense -137.35%-8.55M100.15%74K38.50%22.41M87.25%-8.97M-164.92%-9.77M68.18%-3.6M-2,093.71%-50.42M312.38%16.18M-338.29%-70.32M-34.20%15.04M
-Change in other working capital ---167K---197K---152K----------------------------
Cash from discontinued investing activities
Operating cash flow 3.10%57.11M60.66%329.32M45.37%123.05M971.63%78.44M7.48%72.44M-10.56%55.4M-25.39%204.98M15.42%84.64M-112.16%-9M-32.41%67.4M
Investing cash flow
Cash flow from continuing investing activities 116.81%1.63M77.92%-63.53M-70.63%-20.07M87.60%-30.87M67.27%-2.92M46.60%-9.68M-306.37%-287.76M53.13%-11.76M-6,413.95%-248.96M78.65%-8.91M
Net PPE purchase and sale 66.17%-270K-5.33%-1.74M-20.88%-689K22.95%-188K75.93%-65K-40.49%-798K-258.35%-1.65M-247.56%-570K-275.38%-244K-382.14%-270K
Net business purchase and sale ------0--0---------------267.54M--0--------
Net investment purchase and sale 121.36%1.9M-232.77%-61.79M-73.16%-19.38M-263.03%-30.68M67.00%-2.85M49.42%-8.88M73.61%-18.57M55.11%-11.19M600.90%18.82M79.27%-8.64M
Cash from discontinued investing activities
Investing cash flow 116.81%1.63M77.92%-63.53M-70.63%-20.07M87.60%-30.87M67.27%-2.92M46.60%-9.68M-306.37%-287.76M53.13%-11.76M-6,413.95%-248.96M78.65%-8.91M
Financing cash flow
Cash flow from continuing financing activities 15.43%-21.34M-81.91%-110.25M47.14%-21.82M-109.94%-14.82M57.65%-48.37M53.39%-25.24M56.77%-60.6M39.14%-41.28M256.19%149.03M-152.47%-114.21M
Net issuance payments of debt 55.10%-7.25M-1,036.07%-70.38M-35.92%-21.95M-110.87%-16.15M79.58%-16.15M64.77%-16.15M111.41%7.52M64.77%-16.15M424.10%148.55M-70.86%-79.05M
Net common stock issuance ----58.18%-25.1M--0--0--------19.97%-60.03M-0.10%-25.03M--0----
Proceeds from stock option exercised by employees -34.84%1.34M-49.04%5.64M469.36%985K269.68%2.29M-94.61%308K-54.88%2.06M21.67%11.07M-94.66%173K4.55%620K357.15%5.72M
Net other financing activities -38.44%-15.43M-6.42%-20.4M-208.60%-861K-578.87%-964K-26.43%-7.43M13.41%-11.15M-129.28%-19.17M-19.74%-279K17.44%-142K-2,570.45%-5.88M
Cash from discontinued financing activities
Financing cash flow 15.43%-21.34M-81.91%-110.25M47.14%-21.82M-109.94%-14.82M57.65%-48.37M53.39%-25.24M56.77%-60.6M39.14%-41.28M256.19%149.03M-152.47%-114.21M
Net cash flow
Beginning cash position 161.00%252.16M-59.74%96.61M163.05%171M-20.52%138.25M-49.01%117.09M-59.74%96.61M36.18%239.99M-74.96%65.01M-38.92%173.94M-15.58%229.66M
Current changes in cash 82.59%37.4M208.48%155.55M156.79%81.16M130.07%32.75M137.97%21.15M298.14%20.48M-324.88%-143.38M261.37%31.61M-331.99%-108.93M-536.34%-55.72M
End cash Position 147.29%289.56M161.00%252.16M161.00%252.16M163.05%171M-20.52%138.25M-49.01%117.09M-59.74%96.61M-59.74%96.61M-74.96%65.01M-38.92%173.94M
Free cash flow 4.11%56.84M61.11%327.58M45.54%122.36M946.59%78.25M7.81%72.37M-11.03%54.6M-25.87%203.33M14.90%84.07M-112.50%-9.24M-32.65%67.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More